When.com Web Search

  1. Ads

    related to: how long to live on statins good for diabetics chart

Search results

  1. Results From The WOW.Com Content Network
  2. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    On average, statins can lower LDL cholesterol by 1.8 mmol/L (70 mg/dL), which translates into an estimated 60% decrease in the number of cardiac events (heart attack, sudden cardiac death) and a 17% reduced risk of stroke after long-term treatment. [36] A greater benefit is observed with high-intensity statin therapy. [37]

  3. New Analysis Finds Millions of People on Statins May ... - AOL

    www.aol.com/lifestyle/analysis-finds-millions...

    New research finds that millions of people currently taking statins to lower cholesterol may not actually need this medication to stay heart healthy. ... DC plane crash live updates: 41 bodies ...

  4. Statins are Effective Even for People Over Age 75, What ... - AOL

    www.aol.com/statins-effective-even-people-over...

    Statins appear to be effective at preventing cardiovascular disease and death in older adults, according to new research. Most clinical trials evaluating statins have not included people 75 and ...

  5. Fewer people may need statins to prevent heart disease, new ...

    www.aol.com/news/fewer-people-may-statins...

    In other words, as many as 4 million people in the U.S. who currently take statins for primary prevention — meaning they have not had a cardiovascular event such as a stroke or heart attack ...

  6. Rosuvastatin - Wikipedia

    en.wikipedia.org/wiki/Rosuvastatin

    Meta-analysis showed that rosuvastatin can modestly increase levels of high-density lipoprotein (HDL) cholesterol, as well as with other statins. [12] A 2014 Cochrane review determined there was good evidence for rosuvastatin lowering non-HDL levels linearly with dose.

  7. JUPITER trial - Wikipedia

    en.wikipedia.org/wiki/JUPITER_trial

    JUPITER was a randomized double-blind placebo-controlled study investigating the use of rosuvastatin in the primary prevention of cardiovascular disease.The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP).